Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2021-2027

前立腺特異抗原(PSA)検査の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2776
◆調査・発行会社:QYResearch
◆発行日:2021年6月
◆ページ数:115
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、前立腺特異抗原(PSA)検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(CLIA法、ELISA法)、用途別市場規模(スクリーニング、治療後モニタリング、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・前立腺特異抗原(PSA)検査の市場動向
・企業の競争状況、市場シェア
・前立腺特異抗原(PSA)検査の種類別市場規模(CLIA法、ELISA法)
・前立腺特異抗原(PSA)検査の用途別市場規模(スクリーニング、治療後モニタリング、その他)
・前立腺特異抗原(PSA)検査の北米市場規模2016-2027(アメリカ、カナダ)
・前立腺特異抗原(PSA)検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・前立腺特異抗原(PSA)検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・前立腺特異抗原(PSA)検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・前立腺特異抗原(PSA)検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Boston Scientific Corporation、Bayer AG、Siemens Healthcare、DiaSorin、Roche、Beckman Coulter、PerkinElmer、Tosoh、Ortho Clinical、Fujirebio、Mediwatch、BodiTech、Bristol-Myers Squibb Company、GE Healthcare、Endocare、Merck&Co.、Medtronic、Sanofi-Aventis SA)
・結論

Prostate-specific antigen (PSA) is a protein secreted only by epithelial prostate cells, and its elevation in serum is used to detect prostate cancer in men.Elevated PSA levels are associated with prostatitis, inflammation of the prostate or benign forms of prostatic hyperplasia, making it a valuable tumor marker for prostate cancer.The use of serology-based biomarkers for the diagnosis of prostate cancer has stimulated the need for prostate-specific antigen (PSA).

Market Analysis and Insights: Global Prostate-specific Antigen (PSA) Testing Market
The global Prostate-specific Antigen (PSA) Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate-specific Antigen (PSA) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate-specific Antigen (PSA) Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate-specific Antigen (PSA) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate-specific Antigen (PSA) Testing market.

Global Prostate-specific Antigen (PSA) Testing Scope and Market Size
Prostate-specific Antigen (PSA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate-specific Antigen (PSA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CLIA Method
ELISA Method

Segment by Application
Screening
Post-treatment Monitoring
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck&Co.
Medtronic
Sanofi-Aventis SA

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CLIA Method
1.2.3 ELISA Method
1.3 Market by Application
1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Screening
1.3.3 Post-treatment Monitoring
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prostate-specific Antigen (PSA) Testing Market Perspective (2016-2027)
2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Regions
2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Share by Regions (2016-2021)
2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2022-2027)
2.3 Prostate-specific Antigen (PSA) Testing Industry Dynamic
2.3.1 Prostate-specific Antigen (PSA) Testing Market Trends
2.3.2 Prostate-specific Antigen (PSA) Testing Market Drivers
2.3.3 Prostate-specific Antigen (PSA) Testing Market Challenges
2.3.4 Prostate-specific Antigen (PSA) Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue
3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2016-2021)
3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2016-2021)
3.2 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
3.4 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
3.4.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2020
3.5 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
3.6 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
3.7 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate-specific Antigen (PSA) Testing Breakdown Data by Type
4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2016-2021)
4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2022-2027)

5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application
5.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2016-2021)
5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
6.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type
6.2.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
6.2.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
6.2.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Application
6.3.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
6.3.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
6.3.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Country
6.4.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021)
6.4.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type
7.2.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
7.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
7.2.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application
7.3.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
7.3.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
7.3.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country
7.4.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021)
7.4.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
8.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type
8.2.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application
8.3.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region
8.4.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
9.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type
9.2.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
9.2.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
9.2.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
9.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application
9.3.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
9.3.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
9.3.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
9.4 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country
9.4.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021)
9.4.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
10.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type
10.2.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application
10.3.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country
10.4.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
11.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
11.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.2.5 Boston Scientific Corporation Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
11.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.3.5 Bayer AG Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Details
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
11.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.4.5 Siemens Healthcare Recent Development
11.5 DiaSorin
11.5.1 DiaSorin Company Details
11.5.2 DiaSorin Business Overview
11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
11.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.5.5 DiaSorin Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
11.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Details
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
11.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.7.5 Beckman Coulter Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
11.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.8.5 PerkinElmer Recent Development
11.9 Tosoh
11.9.1 Tosoh Company Details
11.9.2 Tosoh Business Overview
11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
11.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.9.5 Tosoh Recent Development
11.10 Ortho Clinical
11.10.1 Ortho Clinical Company Details
11.10.2 Ortho Clinical Business Overview
11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
11.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.10.5 Ortho Clinical Recent Development
11.11 Fujirebio
11.11.1 Fujirebio Company Details
11.11.2 Fujirebio Business Overview
11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
11.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.11.5 Fujirebio Recent Development
11.12 Mediwatch
11.12.1 Mediwatch Company Details
11.12.2 Mediwatch Business Overview
11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
11.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.12.5 Mediwatch Recent Development
11.13 BodiTech
11.13.1 BodiTech Company Details
11.13.2 BodiTech Business Overview
11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
11.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.13.5 BodiTech Recent Development
11.14 Bristol-Myers Squibb Company
11.14.1 Bristol-Myers Squibb Company Company Details
11.14.2 Bristol-Myers Squibb Company Business Overview
11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
11.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.14.5 Bristol-Myers Squibb Company Recent Development
11.15 GE Healthcare
11.15.1 GE Healthcare Company Details
11.15.2 GE Healthcare Business Overview
11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
11.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.15.5 GE Healthcare Recent Development
11.16 Endocare
11.16.1 Endocare Company Details
11.16.2 Endocare Business Overview
11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
11.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.16.5 Endocare Recent Development
11.17 Merck&Co.
11.17.1 Merck&Co. Company Details
11.17.2 Merck&Co. Business Overview
11.17.3 Merck&Co. Prostate-specific Antigen (PSA) Testing Introduction
11.17.4 Merck&Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.17.5 Merck&Co. Recent Development
11.18 Medtronic
11.18.1 Medtronic Company Details
11.18.2 Medtronic Business Overview
11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
11.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
11.18.5 Medtronic Recent Development
11.18 Sanofi-Aventis SA
.1 Sanofi-Aventis SA Company Details
.2 Sanofi-Aventis SA Business Overview
.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
.5 Sanofi-Aventis SA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CLIA Method
Table 3. Key Players of ELISA Method
Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2016-2021)
Table 8. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2022-2027)
Table 10. Prostate-specific Antigen (PSA) Testing Market Trends
Table 11. Prostate-specific Antigen (PSA) Testing Market Drivers
Table 12. Prostate-specific Antigen (PSA) Testing Market Challenges
Table 13. Prostate-specific Antigen (PSA) Testing Market Restraints
Table 14. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Prostate-specific Antigen (PSA) Testing Market Share by Players (2016-2021)
Table 16. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2020)
Table 17. Ranking of Global Top Prostate-specific Antigen (PSA) Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
Table 21. Date of Enter into Prostate-specific Antigen (PSA) Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Prostate-specific Antigen (PSA) Testing Product
Table 64. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Boston Scientific Corporation Company Details
Table 67. Boston Scientific Corporation Business Overview
Table 68. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product
Table 69. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 70. Boston Scientific Corporation Recent Development
Table 71. Bayer AG Company Details
Table 72. Bayer AG Business Overview
Table 73. Bayer AG Prostate-specific Antigen (PSA) Testing Product
Table 74. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 75. Bayer AG Recent Development
Table 76. Siemens Healthcare Company Details
Table 77. Siemens Healthcare Business Overview
Table 78. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product
Table 79. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 80. Siemens Healthcare Recent Development
Table 81. DiaSorin Company Details
Table 82. DiaSorin Business Overview
Table 83. DiaSorin Prostate-specific Antigen (PSA) Testing Product
Table 84. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 85. DiaSorin Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Prostate-specific Antigen (PSA) Testing Product
Table 89. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Beckman Coulter Company Details
Table 92. Beckman Coulter Business Overview
Table 93. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product
Table 94. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 95. Beckman Coulter Recent Development
Table 96. PerkinElmer Company Details
Table 97. PerkinElmer Business Overview
Table 98. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 99. PerkinElmer Recent Development
Table 100. Tosoh Company Details
Table 101. Tosoh Business Overview
Table 102. Tosoh Prostate-specific Antigen (PSA) Testing Product
Table 103. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 104. Tosoh Recent Development
Table 105. Ortho Clinical Company Details
Table 106. Ortho Clinical Business Overview
Table 107. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product
Table 108. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 109. Ortho Clinical Recent Development
Table 110. Fujirebio Company Details
Table 111. Fujirebio Business Overview
Table 112. Fujirebio Prostate-specific Antigen (PSA) Testing Product
Table 113. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 114. Fujirebio Recent Development
Table 115. Mediwatch Company Details
Table 116. Mediwatch Business Overview
Table 117. Mediwatch Prostate-specific Antigen (PSA) Testing Product
Table 118. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 119. Mediwatch Recent Development
Table 120. BodiTech Company Details
Table 121. BodiTech Business Overview
Table 122. BodiTech Prostate-specific Antigen (PSA) Testing Product
Table 123. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 124. BodiTech Recent Development
Table 125. Bristol-Myers Squibb Company Company Details
Table 126. Bristol-Myers Squibb Company Business Overview
Table 127. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product
Table 128. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 129. Bristol-Myers Squibb Company Recent Development
Table 130. GE Healthcare Company Details
Table 131. GE Healthcare Business Overview
Table 132. GE Healthcare Prostate-specific Antigen (PSA) Testing Product
Table 133. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 134. GE Healthcare Recent Development
Table 135. Endocare Company Details
Table 136. Endocare Business Overview
Table 137. Endocare Prostate-specific Antigen (PSA) Testing Product
Table 138. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 139. Endocare Recent Development
Table 140. Merck&Co. Company Details
Table 141. Merck&Co. Business Overview
Table 142. Merck&Co. Prostate-specific Antigen (PSA) Testing Product
Table 143. Merck&Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 144. Merck&Co. Recent Development
Table 145. Medtronic Company Details
Table 146. Medtronic Business Overview
Table 147. Medtronic Prostate-specific Antigen (PSA) Testing Product
Table 148. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 149. Medtronic Recent Development
Table 150. Sanofi-Aventis SA Company Details
Table 151. Sanofi-Aventis SA Business Overview
Table 152. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product
Table 153. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
Table 154. Sanofi-Aventis SA Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2020 VS 2027
Figure 2. CLIA Method Features
Figure 3. ELISA Method Features
Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2020 VS 2027
Figure 5. Screening Case Studies
Figure 6. Post-treatment Monitoring Case Studies
Figure 7. Other Case Studies
Figure 8. Prostate-specific Antigen (PSA) Testing Report Years Considered
Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions: 2020 VS 2027
Figure 12. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2022-2027)
Figure 13. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2020
Figure 14. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2020
Figure 16. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2016-2021)
Figure 17. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2022-2027)
Figure 18. North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
Figure 20. North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
Figure 21. North America Prostate-specific Antigen (PSA) Testing Market Share by Country (2016-2027)
Figure 22. United States Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
Figure 26. Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
Figure 27. Europe Prostate-specific Antigen (PSA) Testing Market Share by Country (2016-2027)
Figure 28. Germany Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Region (2016-2027)
Figure 38. China Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
Figure 46. Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
Figure 47. Latin America Prostate-specific Antigen (PSA) Testing Market Share by Country (2016-2027)
Figure 48. Mexico Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Country (2016-2027)
Figure 54. Turkey Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 58. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 59. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 60. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 61. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 63. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 64. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 65. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 66. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 67. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 68. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 69. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 70. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 71. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 72. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 73. Merck&Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 74. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 75. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[前立腺特異抗原(PSA)検査の世界市場規模・現状・予測2021年-2027年] (Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2021-2027 / QY21JNE2776)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆